Quarterly ResultMay 15, 2026, 04:10 PM
Positron Corp Reports Q1 Net Loss $1.38M; Going Concern Doubt
AI Summary
Positron Corporation reported a net loss of $1.38 million for Q1 2026, an improvement from $1.51 million in Q1 2025, on sales of $111,000. The company faces substantial doubt about its ability to continue as a going concern due to a significant accumulated deficit, working capital deficiency, and continued cash usage in operations. Management plans to expand its PET-CT system into cardiology and oncology markets and explore strategic partnerships.
Key Highlights
- Net loss for Q1 2026 was $1.38 million, compared to $1.51 million in Q1 2025.
- Sales for Q1 2026 decreased to $111,000 from $119,333 in Q1 2025.
- Cash and cash equivalents declined to $1.41 million from $2.52 million since year-end 2025.
- Accumulated deficit reached $146.31 million as of March 31, 2026.
- Reported a working capital deficiency of $334,061 at quarter-end.
- Stockholders' equity decreased significantly to $160,553 from $1.44 million.
- Net cash used in operating activities was $788,710 for the quarter.
- Incurred an inventory write-down of $220,183 in Q1 2026.
Price Impact